CSF1R and central nervous system cancer: Glioma cell proliferation was reduced by half with the CSF-1R inhibitor alone (Cohen’s d = 1.4 [0.6, 3.7]) and decreased nearly fivefold when combined with IR (Cohen’s d = 2.9 [1.0, 9.1]; see Fig. 8(B)).